Megestrol Acetate Suspension
Product Images NDC 70954-896

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Megestrol Acetate (NDC 70954-896). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-1 (240ml)

This is a description of Megestrol Acetate Oral Suspension, USP, with a concentration of 40 mg/mL. It is recommended to shake well before dosing. Each mL contains 40 mg of micronized megestrol acetate in a lemon-lime flavored oral suspension. The package insert provides information on indications and dosage. It should be stored at room temperature and dispensed in a tight container away from heat. The medication should be kept out of the reach of children. Distributed by AN Pharmaceuticals, Inc. at Baudette, MN. Issue date: 12/7/2024. Batch number: LB4G34-00.*

FDA Label Image

Label-2 (480ml)

This is a description of Megestrol Acetate oral suspension, USP, with a concentration of 40 mg/mL. It is recommended to shake well before dosing, and each mL contains 40 mg of micronized megestrol acetate in lemon-lime flavored oral suspension. The packaging insert should be consulted for indications and dosage schedule. The medication should be stored at 20°C to 25°C (68°F to 77°F) in a controlled room temperature environment. It should be dispensed in a tight container and protected from heat, kept out of reach of children. This product is distributed by ANI Pharmaceuticals Inc. in Baudette, MN 56623. The issue date is 02/2024.*

FDA Label Image

Graph (Graph)

FDA Label Image

Image 1 (Image 1)

This is not a readable text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.